Thermo Fisher Scientific | TMO - Assets


Thermo Fisher Scientific reported $113.17B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Agilent USD 13.07B 252M Mar/2026
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Bio Techne USD 2.55B 27.9M Mar/2026
Bio-Rad Laboratories USD 10.25B 462M Jun/2026
Boston Scientific USD 45.22B 865M Jun/2026
Bruker USD 6.05B 77.8M Jun/2026
Charles River Laboratories USD 7.53B 198.16M Jun/2026
Danaher USD 92.37B 8.82B Jun/2026
Dentsply International USD 5.2B 25M Jun/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
General Electric Aerospace USD 127.67B 773M Jun/2026
Henry Schein USD 11.38B 77M Jun/2026
Illumina USD 6.65B 91M Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
IQVIA Holdings USD 29.88B 206M Jun/2026
Laboratory Of America USD 18.53B 554.8M Jun/2026
Medtronic USD 91.48B 139M Dec/2025
Mettler Toledo International USD 3.67B 2.03M Jun/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
Olympus JPY 1.54T 79.24B Mar/2026
OraSure Technologies USD 379.17M 24M Mar/2026
Quest Diagnostics USD 16.94B 266M Jun/2026
Repligen USD 2.95B 19.41M Jun/2026
Revvity USD 12.05B 49.24M Jun/2026
Stryker USD 47.93B 1.64B Jun/2026
Thermo Fisher Scientific USD 113.17B 107M Jun/2026
Veracyte USD 1.49B 49.97M Jun/2026
Waters USD 24.75B 220M Jun/2026
Zimmer Biomet Holdings USD 22.8B 76.2M Jun/2026